Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer’s disease cases
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1619-7089
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer’s disease cases ; day:24 ; month:9 ; year:2020 ; pages:1-10
European journal of nuclear medicine and molecular imaging ; (24.9.2020), 1-10
- Urheber
-
Malarte, Mona-Lisa
Nordberg, Agneta
Lemoine, Laetitia
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00259-020-05035-y
- URN
-
urn:nbn:de:101:1-2020111218004016562173
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Malarte, Mona-Lisa
- Nordberg, Agneta
- Lemoine, Laetitia
- SpringerLink (Online service)
Ähnliche Objekte (12)
CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PET
Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET
Clinical evaluation of [18F] JNJ-64326067, a novel candidate PET tracer for the detection of tau pathology in Alzheimer’s disease
Dosimetry and efficacy of a tau PET tracer [18F]MK-6240 in Japanese healthy elderly and patients with Alzheimer’s disease
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Cryo-EM structure of Alzheimer’s disease tau filaments with PET ligand MK-6240
Deep learning detection of informative features in tau PET for Alzheimer’s disease classification
Tau PET correlates with different Alzheimer’s disease‐related features compared to CSF and plasma p‐tau biomarkers
Optimal blood tau species for the detection of Alzheimer’s disease neuropathology: an immunoprecipitation mass spectrometry and autopsy study
Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum
CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PET
Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET
Clinical evaluation of [18F] JNJ-64326067, a novel candidate PET tracer for the detection of tau pathology in Alzheimer’s disease
Dosimetry and efficacy of a tau PET tracer [18F]MK-6240 in Japanese healthy elderly and patients with Alzheimer’s disease
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Cryo-EM structure of Alzheimer’s disease tau filaments with PET ligand MK-6240
Deep learning detection of informative features in tau PET for Alzheimer’s disease classification
Tau PET correlates with different Alzheimer’s disease‐related features compared to CSF and plasma p‐tau biomarkers
Optimal blood tau species for the detection of Alzheimer’s disease neuropathology: an immunoprecipitation mass spectrometry and autopsy study
Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum
CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PET
Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET
Clinical evaluation of [18F] JNJ-64326067, a novel candidate PET tracer for the detection of tau pathology in Alzheimer’s disease
Dosimetry and efficacy of a tau PET tracer [18F]MK-6240 in Japanese healthy elderly and patients with Alzheimer’s disease
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Cryo-EM structure of Alzheimer’s disease tau filaments with PET ligand MK-6240
Deep learning detection of informative features in tau PET for Alzheimer’s disease classification
Tau PET correlates with different Alzheimer’s disease‐related features compared to CSF and plasma p‐tau biomarkers
Optimal blood tau species for the detection of Alzheimer’s disease neuropathology: an immunoprecipitation mass spectrometry and autopsy study